Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.
The company posted quarterly earnings of 12 cents per share, compared to market estimates for a loss of 3 cents per share. The company’s quarterly sales came in at $81.17 million versus expectations of $68.51 million.
TransMedics Group shares jumped 23.5% to $96.00 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Janux Therapeutics, Inc. (NASDAQ: JANX) gained 85.5% to $28.01 in pre-market trading after the company announced updated clinical data for both of its clinical programs.
- PubMatic, Inc. (NASDAQ: PUBM) shares rose 35.7% to $22.49 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.
- Galera Therapeutics, Inc. (NASDAQ: GRTX) shares gained 37% to $0.2630 in pre-market trading. Galera Therapeutics 10% owner Yair Schneid acquired a total of 932,402 shares at an average price of $0.18.
- Infobird Co., Ltd (NASDAQ: IFBD) shares surged 36.2% to $3.76 in pre-market trading after dipping 27% on Monday. Infobird announced a Delay in ...